Author:
Ito Yoshinori,Tokudome Nahomi,Sugihara Tsutomu,Takahashi Shunji,Hatake Kiyohiko
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Radiology Nuclear Medicine and imaging,Oncology,General Medicine
Reference45 articles.
1. Slamon DJ, Leyland-Jones B, Shak S, Fuchs H, Paton V, Bajamonde A, Fleming T, Eiermann W, Wolter J, Pegram M, Baselga J, Norton L: (Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2).N Engl J Med 344:783–792, 2001.
2. Romond EH, Perez EA, Bryant J, Suman VJ, Geyer CE Jr, Davidson NE, Tan-Chiu E, Martino S, Paik S, Kaufman PA, Swain SM, Pisansky TM, Fehrenbacher L, Kutteh LA, Vogel VG, Visscher DW, Yothers G, Jenkins RB, Brown AM, Dakhil SR, Mamounas EP, Lingle WL, Klein PM, Ingle JN, Wolmark N: (Tras-tuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer).N Engl J Med 353:1673–1684, 2005.
3. Piccart-Gebhart MJ, Procter M, Leyland-Jones B, Goldhirsch A, Untch M, Smith I, Gianni L, Baselga J, Bell R, Jackisch C, Cameron D, Dowsett M, Barrios CH, Steger G, Huang CS, Andersson M, Inbar M, Lichinitser M, Lang I, Nitz U, Iwata H, Thomssen C, Lohrisch C, Suter TM, Ruschoff J, Suto T, Greatorex V, Ward C, Straehle C, McFadden E, Dolci MS, Gel-ber RD; Herceptin Adjuvant (HERA) Trial Study Team: (Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer).N Engl J Med 353:1659–1672, 2005.
4. Savona M, Talpaz M: (Chronic myeloid leukemia: changing the treatment paradigms).Oncology 20:707–711, 2006.
5. Held G, Poschel V, Pfreundschuh M: Monoclonal antibody therapy for B-cell malignancies.Semin Oncol 2:s2–14, 2006.
Cited by
22 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献